Dr. Markowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
99 Beauvoir Ave
Summit, NJ 07901Phone+1 908-608-0078
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2013 - 2016
Rutgers Robert Wood Johnson Medical SchoolClass of 2013- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology
Certifications & Licensure
NJ State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 54 citationsFunctional Analysis of 11q13.5 Amplicon Identifies Rsf-1 (HBXAP) as a Gene Involved in Paclitaxel Resistance in Ovarian CancerJung Hye Choi, Jim Jinn-Chyuan Sheu, Bin Guan, Natini Jinawath, Paul Markowski
Cancer Research. 2009-02-15 - 53 citationsIdentifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, Jeffrey S. Ross, Dean Pavlick
JCO Precision Oncology. 2017-12-07 - 4 citationsMulticenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell CarcinomaMichael E. Hurwitz, Paul Markowski, Xiaopan Yao, Hari Anant Deshpande, Jaymin M. Patel
Clinical Genitourinary Cancer. 2018-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
